IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,701,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,850,000 | $12,513,000 | 4.70% |
| Avoro Capital Advisors LLC | 7,344,177 | $23,869,000 | 4.19% |
| NEXTHERA CAPITAL LP | 1,263,276 | $4,106,000 | 2.52% |
| Opaleye Management Inc. | 1,200,000 | $3,900,000 | 2.04% |
| First Light Asset Management, LLC | 992,867 | $3,227,000 | 1.39% |
| DAFNA Capital Management LLC | 566,796 | $1,842,000 | 1.28% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,500,000 | 1.05% |
| Iguana Healthcare Management, LLC | 600,000 | $1,950,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 319,565 | $1,039,000 | 0.32% |
| J. Goldman & Co LP | 1,696,699 | $5,514,000 | 0.31% |